RISK DRIVERS OF FALSIFIED AND SUB-STANDARD MEDICINES IN EAST AFRICA: PERCEPTIONS AND PRACTICES OF PHARMACEUTICAL DRUG FACILITY OWNERS/EMPLOYEES
Journal Title: International Journal of Drug Regulatory Affairs - Year 2014, Vol 2, Issue 3
Abstract
An interview survey was conducted among drug shop owners to investigate the access to and perception of counterfeit medication along transport corridors of East Africa spanning Kenya, Tanzania, Uganda and Democratic Republic of Congo. Owners of 171 retail drug outlets of modern medicines were interviewed on their knowledge, perception, and practices related to counterfeit medicines. Forty-four (44) encounters with counterfeit medicines were reported. Twenty-two (22) of the 171 interviewed drug store owners said that quality was the least important aspect they considered when procuring drugs. Generally, 65.9% of the drugs were sourced from registered wholesalers and distributors while the remaining 34.1% were supplied by unregistered in-country or cross-border sales representatives. In all the four countries, the 10 fastest moving drugs were reported to originate from 27 different countries with most (39%) from India. From 171 interviewees, 135 acknowledged that they were aware of the existence of counterfeit drugs, 106 of whom attributed their level of awareness to mass media. Only 32 of the interviewees reported having received any formal training on counterfeit medicines at seminars or workshops. 160 of the interviewees acknowledged that counterfeit drugs pose a major threat to the patient and pharmaceutical market. The region has a plethora of drug outlets run by attendants with varying backgrounds, diverse knowledge on medicines and practice patterns. There is an urgent need for medicine regulators and other stakeholders in Africa involved in medicine safety, to focus on properly regulating these outlets and also standardizing and training the drug outlet personnel.
Authors and Affiliations
Fomundam Henry, Tesfay A, Maranga A, Oyaro F, Kambafwile H.
Keywords
Related Articles
- EP ID EP349814
- DOI 10.22270/ijdra.v2i3.9
- Views 79
- Downloads 0
OCULAR DRUG DELIVERY: RECENT UPDATES
Ophthalmic route is one of the most promising delivery systems for the treatment of eye ailments. Delivery of medicaments to anterior segment of the eye is an easy task. However with the rising number of posterior segmen...
Regulatory requirements for Vaccine registration in United States
Vaccination is one among the foremost cost-efficient health interventions out available, saving a lot of individuals from illness, incapacity, and death annually. No alternative countermeasures are effective in reducing...
Covering Global Pharmaceutical Regulations in a Quality System
This article describes how to address compliance with a wide range of applicable regulations within a company’s quality system. The focus is on the way regulatory intelligence can be obtained and subsequently be interpre...
STEVIA AN UNTOUCHED NATURE’S GIFT CAN BE A BOON TO DIABETIC
Plants and fungi are a vital part of healthcare. Over 80% of the global population rely on traditional medicine, much of which is based on plant remedies. Traditional Chinese medicine alone uses over 5,000 plant species....
ADVANCES IN THE REVIEW OF GENERIC DRUG APPLICATIONS BY UNITED STATES FOOD AND DRUG ADMINISTRATION, A REGULATORY PERSPECTIVE IN THE ERA OF GDUFA (GENERIC DRUG USER FEE AMENDMENT 2012)
A regulatory process, by which a person/organization/sponsor/innovator gets authorization to launch a drug in the market, is known as drug approval process. The United States - Food and Drug Administration (U.S. FDA) has...